{"transactions":[{"id":725559,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:21:00.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045780","document":"wk-form4_1782505258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000162828026045780/wk-form4_1782505258.xml","form_type":"4"}},{"id":1113578,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:23:33.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000073","document":"wk-form4_1749763407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295225000073/wk-form4_1749763407.xml","form_type":"4"}},{"id":1479146,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T11:47:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-24-000044","document":"wk-form4_1718365616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295224000044/wk-form4_1718365616.xml","form_type":"4"}},{"id":1836520,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T20:11:02.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":23382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was awarded pursuant to the \"elective option\" provisions of the Issuer's non-employee director compensation program for the Reporting Person's service on the Issuer's Board and certain of its committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date."}],"balance_after":23382,"derivative":{"exercise_price":3.12,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":23382},"source":{"system":"sec-edgar","filing":"0000950170-23-031628","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000095017023031628/ownership.xml","form_type":"4"}},{"id":1852466,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:15:21.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":48000,"derivative":{"exercise_price":3.27,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0000899243-23-015766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924323015766/doc4.xml","form_type":"4"}},{"id":1873405,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T20:53:30.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-23-000061","document":"wf-form4_168556639644192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295223000061/wf-form4_168556639644192.xml","form_type":"4"}},{"id":2214886,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-05T20:05:39.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":58496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was awarded pursuant to the \"elective option\" provisions of the Issuer's non-employee director compensation program for the Reporting Peron's service on the Issuer's Board and certain of its\ncommittees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date."}],"balance_after":58496,"derivative":{"exercise_price":1.29,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":58496},"source":{"system":"sec-edgar","filing":"0000899243-22-024971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924322024971/doc4.xml","form_type":"4"}},{"id":2230084,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:05:49.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of June 15, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.48,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-022790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924322022790/doc4.xml","form_type":"4"}},{"id":2244989,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:10:59.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000060","document":"wf-form4_165428703516071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295222000060/wf-form4_165428703516071.xml","form_type":"4"}},{"id":2464072,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T23:30:17.000Z","date":"2021-12-17","kind":"purchase","acquired":true,"shares":20000,"price":2.7402,"value":54804.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.725 to $2.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote"}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0000899243-21-049012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321049012/doc4.xml","form_type":"4"}},{"id":2641505,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T22:16:16.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":8730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was awarded pursuant to the \"elective option\" provisions of the Issuer's non-employee director compensation program for the Reporting Peron's service on the Issuer's Board and certain of its committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date."}],"balance_after":8730,"derivative":{"exercise_price":10.09,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":8730},"source":{"system":"sec-edgar","filing":"0000899243-21-027606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321027606/doc4.xml","form_type":"4"}},{"id":2664044,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T22:41:13.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":9888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":9888,"derivative":{"exercise_price":8.9,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":9888},"source":{"system":"sec-edgar","filing":"0000899243-21-024505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321024505/doc4.xml","form_type":"4"}},{"id":2664043,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T22:41:13.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":10000,"price":9.13,"value":91300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.01 to $9.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000899243-21-024505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321024505/doc4.xml","form_type":"4"}},{"id":2681115,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-05T00:13:28.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":10000,"price":8.6511,"value":86511.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.49 to $8.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000899243-21-022167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321022167/doc4.xml","form_type":"4"}},{"id":2686824,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-02T21:35:11.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":10000,"price":8.6381,"value":86381.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.59 to $8.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-21-021576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321021576/doc4.xml","form_type":"4"}},{"id":2686823,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-02T21:35:11.000Z","date":"2021-05-28","kind":"purchase","acquired":true,"shares":10000,"price":8.641,"value":86410.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.59 to $8.6759, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-021576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924321021576/doc4.xml","form_type":"4"}},{"id":3186864,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T12:13:15.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":19776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six (36) substantially equal monthly installments, such that the option shall be fully vested on March 31, 2023."}],"balance_after":19776,"derivative":{"exercise_price":9.5,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":19776},"source":{"system":"sec-edgar","filing":"0000899243-20-009939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000089924320009939/doc4.xml","form_type":"4"}}]}